The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

Abstract Background The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods systematic review to explore the impact of these changes on program effectiveness and client experiences in OAT. Methods The...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter, Eugenia Oviedo-Joekes
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-09-01
Colecção:	Substance Abuse Treatment, Prevention, and Policy
Assuntos:	Substance use Opioid use disorder Opioid agonist treatment COVID-19
Acesso em linha:	https://doi.org/10.1186/s13011-023-00564-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!